Edwards Lifesciences Net Cash Flow from Financing Trend

EW -- USA Stock  

USD 153.68  11.79  7.13%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow from Financing of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities; from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares; issuance (repayment) of debt securities; and payment of dividends & other cash distributions.
Net Cash Flow from Financing10 Years Trend
Decreasing
Slightly volatile
 Net Cash Flow from Financing 
      Timeline 

Edwards Lifesciences Regression Statistics

Arithmetic Mean(144,807,456)
Coefficient Of Variation(58.43)
Mean Deviation 60,024,123
Median(135,200,000)
Standard Deviation 84,605,504
Range 303,400,000
R Value(0.62)
R Squared 0.39
Significance 0.029951
Slope(14,653,791)

Edwards Lifesciences Net Cash Flow from Financing Over Time

2016-12-31 (268,500,000) 
2017-12-31 (268,500,000) 
2018-12-31 (224,789,474) 

Other Fundumenentals of Edwards Lifesciences

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Fundamental Drivers

Edwards Lifesciences Corporation Fundamental Market Drivers

Short Percent Of Float1.27%
Forward Price Earnings29.27
Shares Short Prior Month2.66M
Average Daily Volume Last 10 Day1.1M
Average Daily Volume In Three Month1.15M
Date Short InterestAugust 31, 2018
Fifty Day Average142.32
Two Hundred Day Average141.80

Edwards Lifesciences Upcoming Events

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com